|
PH31122A
(en)
|
1993-03-31 |
1998-02-23 |
Eisai Co Ltd |
Nitrogen-containing fused-heterocycle compounds.
|
|
JP4342007B2
(ja)
*
|
1998-08-10 |
2009-10-14 |
大日本住友製薬株式会社 |
キナゾリン誘導体
|
|
CA2557372C
(en)
|
2004-03-05 |
2013-01-08 |
F. Hoffmann-La Roche Ag |
Diaminopyrimidines as p2x3 and p2x2/3 antagonists
|
|
CN101300012B
(zh)
*
|
2005-09-01 |
2011-09-14 |
弗·哈夫曼-拉罗切有限公司 |
作为p2x3和p2x2/3调节剂的二氨基嘧啶类化合物在制备治疗呼吸系统疾病的药物中的应用
|
|
MX2008014689A
(es)
|
2006-05-23 |
2008-11-27 |
Hoffmann La Roche |
Derivados de piridopirimidininona.
|
|
EP2038264B1
(en)
|
2006-06-29 |
2016-10-26 |
F.Hoffmann-La Roche Ag |
Tetrazole-substituted arylamides
|
|
TW200840584A
(en)
|
2006-12-26 |
2008-10-16 |
Gilead Sciences Inc |
Pyrido(3,2-d)pyrimidines useful for treating viral infections
|
|
EP2136639B1
(en)
|
2007-04-02 |
2016-03-09 |
Evotec AG |
Pyrid-2-yl fused heterocyclic compounds, and compositions and uses thereof
|
|
PT2139334E
(pt)
|
2007-04-17 |
2013-10-02 |
Evotec Ag |
Compostos heterocíclicos fusionados de 2-cianofenilo, e composições e utilizações dos mesmos
|
|
CA2715835C
(en)
|
2008-02-29 |
2017-03-21 |
Renovis, Inc. |
Amide compounds, compositions and uses thereof
|
|
JP5608655B2
(ja)
|
2008-09-18 |
2014-10-15 |
エヴォテック アーゲー |
Ｐ２ｘ３受容体活性のモジュレーター
|
|
BRPI0919488A2
(pt)
|
2008-09-30 |
2015-12-01 |
Astrazeneca Ab |
composto, uso de um composto, método para tratar câncer em um animal de sangue quente, composição farmacêutica, e, processo para preparar um composto
|
|
PL2399910T3
(pl)
|
2009-02-13 |
2014-09-30 |
Shionogi & Co |
Pochodne triazyny jako antagoniści receptora p2x3 i/albo p2x2/3 i kompozycja farmaceutyczna zawierająca je
|
|
WO2011041655A1
(en)
*
|
2009-10-01 |
2011-04-07 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Quinazolin-4-amine derivatives; and methods of use
|
|
JP2013545749A
(ja)
|
2010-11-10 |
2013-12-26 |
インフィニティー ファーマシューティカルズ， インコーポレイテッド |
複素環化合物及びその使用
|
|
KR101685862B1
(ko)
|
2012-12-27 |
2016-12-20 |
에프. 호프만-라 로슈 아게 |
Comt 억제제
|
|
WO2016053794A1
(en)
|
2014-09-30 |
2016-04-07 |
Bristol-Myers Squibb Company |
Quinazoline-based kinase inhibitors
|
|
JPWO2016084922A1
(ja)
|
2014-11-28 |
2017-09-07 |
塩野義製薬株式会社 |
１，２，４−トリアジン誘導体およびその医薬組成物
|
|
WO2016088838A1
(ja)
|
2014-12-04 |
2016-06-09 |
塩野義製薬株式会社 |
プリン誘導体およびその医薬組成物
|
|
EP3230281B1
(en)
|
2014-12-09 |
2021-05-26 |
Bayer Aktiengesellschaft |
1,3-thiazol-2-yl substituted benzamides
|
|
WO2017011729A1
(en)
|
2015-07-16 |
2017-01-19 |
Patara Pharma, LLC |
Combination therapies for the treatment of lung diseases
|
|
DK3355889T3
(da)
|
2015-09-29 |
2023-05-15 |
Afferent Pharmaceuticals Inc |
Diaminopyrimidin-p2x3- og p2x2/3-receptormodulatorer til anvendelse i behandling af hoste
|
|
JP6882289B2
(ja)
*
|
2015-11-25 |
2021-06-02 |
コンバージーン・リミテッド・ライアビリティ・カンパニーＣｏｎｖｅｒｇｅｎｅ Ｌｌｃ |
二環式ｂｅｔブロモドメイン阻害剤及びその使用
|
|
CN106565684B
(zh)
|
2016-03-18 |
2019-06-18 |
南方医科大学 |
6-吡唑取代喹唑啉类化合物及其衍生物、合成方法及其应用
|
|
CA3029457A1
(en)
|
2016-06-30 |
2018-01-04 |
Gilead Sciences, Inc. |
4,6-diaminoquinazolines as cot modulators and methods of use thereof
|
|
GB201700814D0
(en)
|
2017-01-17 |
2017-03-01 |
Liverpool School Tropical Medicine |
Compounds
|
|
US11000491B2
(en)
|
2017-05-05 |
2021-05-11 |
Hepanova, Inc. |
Amino-aryl-benzamide compounds and methods of use thereof
|
|
RS63661B1
(sr)
*
|
2018-07-25 |
2022-11-30 |
Faes Farma Sa |
Piridopirimidini kao inhibitori histaminskog h4-receptora
|
|
CN109721554A
(zh)
|
2019-01-08 |
2019-05-07 |
贵州大学 |
一类4-氨基喹唑啉类化合物及其制备方法和应用
|
|
JP7797204B2
(ja)
|
2019-05-31 |
2026-01-13 |
キエシ・フアルマチエウテイチ・ソチエタ・ペル・アチオニ |
Ｐ２ｘ３阻害剤としてのピリドピリミジン誘導体
|
|
CA3139018A1
(en)
|
2019-05-31 |
2020-12-03 |
Chiesi Farmaceutici S.P.A. |
Amino quinazoline derivatives as p2x3 inhibitors
|